A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Progressive Supranuclear PalsyCorticobasal Degeneration
Interventions
DRUG

Lithium

All participants will receive lithium. The dosage will be titrated over a 5-week period and then continued for an additional 6 months.

Trial Locations (9)

10003

Beth Israel Medical Center, New York

21201

University of Maryland, Baltimore

29401

Medical University of South Carolina, Charleston

40202

University of Louisville, Louisville

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

08901

UMDNJ Robert Wood Johnson Medical School, New Brunswick

97239-3098

Oregon Health & Science University, Portland

NE4 5PL

Newcastle University, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Westat

OTHER